Literature DB >> 8438156

Deletion of IRF-1, mapping to chromosome 5q31.1, in human leukemia and preleukemic myelodysplasia.

C L Willman1, C E Sever, M G Pallavicini, H Harada, N Tanaka, M L Slovak, H Yamamoto, K Harada, T C Meeker, A F List.   

Abstract

One of the most frequent cytogenetic abnormalities in human leukemia and myelodysplasia is an interstitial deletion within chromosome 5q. A tumor suppressor gene has been hypothesized to lie in 5q31, the smallest commonly deleted region. IRF-1, a gene whose product manifests anti-oncogenic activity, was mapped to 5q31.1. IRF-1 lies between IL-5 and CDC25C and is centromeric to IL-3 and GM-CSF. Among these genes, only IRF-1 was consistently deleted at one or both alleles in 13 cases of leukemia or myelodysplasia with aberrations of 5q31. Inactivating rearrangements of one IRF-1 allele, accompanied by deletion of the second allele, were also identified in one case of acute leukemia. Thus, IRF-1 may be a critically deleted gene in human leukemia and myelodysplasia.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8438156     DOI: 10.1126/science.8438156

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  83 in total

1.  A novel interferon regulatory factor (IRF), IRF-10, has a unique role in immune defense and is induced by the v-Rel oncoprotein.

Authors:  Jirí Nehyba; Radmila Hrdlicková; Joan Burnside; Henry R Bose
Journal:  Mol Cell Biol       Date:  2002-06       Impact factor: 4.272

2.  Altered immune response of interferon regulatory factor 1-deficient mice against Plasmodium berghei blood-stage malaria infection.

Authors:  R S Tan; C Feng; Y Asano; A U Kara
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

3.  The 5q- syndrome: biology and treatment.

Authors:  Eric Padron; Rami Komrokji; Alan F List
Journal:  Curr Treat Options Oncol       Date:  2011-12

4.  Docking-dependent ubiquitination of the interferon regulatory factor-1 tumor suppressor protein by the ubiquitin ligase CHIP.

Authors:  Vikram Narayan; Emmanuelle Pion; Vivien Landré; Petr Müller; Kathryn L Ball
Journal:  J Biol Chem       Date:  2010-10-14       Impact factor: 5.157

5.  Leveraging Genome and Phenome-Wide Association Studies to Investigate Genetic Risk of Acute Lymphoblastic Leukemia.

Authors:  Eleanor C Semmes; Jayaram Vijayakrishnan; Chenan Zhang; Jillian H Hurst; Richard S Houlston; Kyle M Walsh
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-05-28       Impact factor: 4.254

Review 6.  Tumor-suppressor genes: news about the interferon connection.

Authors:  P Lengyel
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-01       Impact factor: 11.205

7.  Autoimmune manifestations in human myelodysplasia: a positive correlation with interferon regulatory factor-1 (IRF-1) expression.

Authors:  S Giannouli; D Tzoanopoulos; K Ritis; G Kartalis; H M Moutsopoulos; M Voulgarelis
Journal:  Ann Rheum Dis       Date:  2004-05       Impact factor: 19.103

8.  Tumor suppressive protein gene associated with retinoid-interferon-induced mortality (GRIM)-19 inhibits src-induced oncogenic transformation at multiple levels.

Authors:  Sudhakar Kalakonda; Shreeram C Nallar; Ping Gong; Daniel J Lindner; Simeon E Goldblum; Sekhar P Reddy; Dhananjaya V Kalvakolanu
Journal:  Am J Pathol       Date:  2007-09-06       Impact factor: 4.307

9.  Gene network signaling in hormone responsiveness modifies apoptosis and autophagy in breast cancer cells.

Authors:  Robert Clarke; Ayesha N Shajahan; Rebecca B Riggins; Younsook Cho; Anatasha Crawford; Jianhua Xuan; Yue Wang; Alan Zwart; Ruchi Nehra; Minetta C Liu
Journal:  J Steroid Biochem Mol Biol       Date:  2009-03       Impact factor: 4.292

Review 10.  Cytokine therapeutics: lessons from interferon alpha.

Authors:  J U Gutterman
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.